INS and breast carcinoma: Insulin users (47% type 1 diabetes women) were more often premenopausal compared to non-insulin users (p = 0.04); and insulin users with premenopausal breast cancer had lower BMI compared to those not treated with insulin (p = 0.0003) (S4 Table).